Schedule 13D ownership disclosure

Zenas Biopharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 98937L105

Event date: 2025-05-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Leon O. Moulder, Jr.Reported CIK 0001228865

    Shares: 2,098,646.00 · Class: 5.0%

  • Tellus BioVentures, LLC

    Shares: 1,672,039.00 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-057322
Form type
SCHEDULE 13D
Filer
MOULDER LEON O JR
CIK
CIK 1228865
Filed
Jun 06, 2025
Reporting period
May 30, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub